期刊文献+

补肾活血法对肾性骨病患者全段甲状旁腺素与骨特异性碱性磷酸酶的影响 被引量:14

Influences of Therapy of Reinforcing Kidney and Activating Blood on Parathormone and AlkalinePhos phatase of Patient with Renal Osteopathy
原文传递
导出
摘要 目的探讨补肾活血法对慢性肾功能衰竭肾性骨病(RBD)患者甲状旁腺功能亢进及骨代谢异常的改善作用及其机理,并与单纯补肾法相对比。方法采用交叉设计方法比较补肾活血法与单纯补肾法对肾性骨病患者全段甲状旁腺激素(I-PTH)、骨特异性碱性磷酸酶(BAP)指标的影响。结果补肾活血法治疗后血清I-PTH、BAP水平较治疗前均有所下降;单纯补肾法治疗后血清I-PTH、BAP水平较治疗前均显著升高。结论补肾活血中药可以缓解RBD患者甲状旁腺功能亢进的状态,有效改善骨代谢异常,从而延缓RBD的进展。 Objective To discuss the effect of the therapy of reinforcing kidney and activating blood on hyperparathyroidism and abnormal bone metabolism in the patients with renal osteopathy induced by chronic renal insufficiency (CRI), investigate the mechanism of this therapy and compare it with the therapy of reinforcing kidney only. Method A cross-design method was used to compare the influences of the therapy of reinforcing kidney and activating blood on parathormone (I-PTH), bone alkaline phosphatase (BAP) in the patients with that of the therapy of reinforcing kidney only. Result The levels of serum I-PTH and BAD decreased after the treatment with the therapy of reinforcing kidney and activating blood, but that increased obviously after the treatment with the therapy of reinforcing kidney only. Conclusion The therapy of reinforcing kidney and activating blood can alleviate hyperparathyroidism, relieve abnormal bone metabolism and delay the development of renal osteopathy.
出处 《北京中医药大学学报(中医临床版)》 2005年第4期1-3,共3页 Journal of Beijing University of Traditional Chinese Medicine
基金 国家中医药管理局课题(No.00-01LP59)
关键词 肾性骨病 肾性骨营养不良 补肾活血 症状学 renal osteopathy renal osteodystrophy reinforcing kidney and activating blood symptomatology
  • 相关文献

参考文献4

二级参考文献18

  • 1楼鼎秀,马骏先.肾功能不全及肾衰患者血1,25(OH)2D3PTH的改变及其关系探讨[J].中华肾脏病杂志,1989,5(6):331-334. 被引量:1
  • 2[1]Kristian K,Yres D,Sandrine M et al."Uremic Cardiomyopathy”Nephrol Dial Transplant,1998,13(Suppl 4):39
  • 3[2]Sahn DJ,De Maria A.Recommendations regarding quantitation in M-mode echocardiographic measurements.Circulation,1978,58:1072
  • 4[3]Devereux RB,Reichek N.Echocardiographic determination of left ventricular mass in man:Anatomic validation of the method.Circulation,1977,55:613
  • 5[4]Kannel WB,Gordon T,Offutt D.Left ventricular hypertrophy by electrocardiogram:Prevalence,incidence and mortality in the Framingham Study.Ann Intern Med,1969,71:89
  • 6[5]Kannel WB,Doyle JT,McNamara PM et al.Precursors of sudden coronary death:Factors related to the incidence of sudden death.Circulation,1975,51:606
  • 7[6]Levy D,Garrison RJ,Savage DD et al.Left ventricular mass predicts coronary disease events independent of the standard risk factors(abstract).Circulation,1987,76(Suppl Ⅳ):Ⅳ-435
  • 8[7]Parfrey PS,Harnett JD,Griffiths SM et al.The clinical course of left ventricular hypertrophy in dialysis patients.Nephron,1990,55:114
  • 9[8]Greaves SC,Gamble GD,Collins JF et al.Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure.Am J Kidney Dis,1994,24(5):768
  • 10[9]Cannella G,Paoletti E.Myocardial hypertrophy in chronic renal failure:A multifactorial,reversible alteration.Contrib Nephrol,1996,119:135

共引文献30

同被引文献200

引证文献14

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部